MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Gabapentin 400mg capsules (Accord Healthcare Ltd).

Stability Notes

Darkens on exposure to light so must be stored in airtight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Colchicine 500microgram tablets (Wockhardt UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Gabapentin 600mg tablets (Accord Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Gabapentin 800mg tablets (Accord Healthcare Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Liothyronine 20microgram tablets (Morningside Healthcare Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Liothyronine 5microgram tablets (Morningside Healthcare Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Pro-Banthine 15mg tablets (Kyowa Kirin Ltd).

Stability Notes

Store in air-tight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Cardicor 2.5mg tablets (Merck Serono Ltd).

Stability Notes

Store in air-tight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Cardicor 5mg tablets (Merck Serono Ltd).

Stability Notes

Store in air-tight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Cardicor 10mg tablets (Merck Serono Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.